Johnson Matthey Catalysis and Chiral Technologies Introduces Catalytic Reaction Guide Mobile Application
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division, has announced the launch of its Catalytic Reaction Guide (CRG) as a free mobile application. The app has been introduced to provide customers mobile access to catalyst recommendations on more than 150 chemical reactions in the area of homogeneous, heterogeneous and asymmetric catalysis. Users can easily view and search a full product listing with streamlined technical support, take advantage of an efficient quotation request process, and obtain contact information for a complete services offering.
As the only app of its kind on the market, JMCCT was motivated to make the guide mobile to enable informed purchasing decisions anywhere in the world. In addition to catalyst recommendations, the app features a convenient Chemical Abstracts Service searchable product listing and relevant literature references. The interface is fully customizable through a user profile that synchronizes data with other devices for easy tracking of recommendations and details.
“JMCCT strives to stay at the forefront of technology, not only in the products we offer, but in how we communicate with our customers. The CRG app is a cutting-edge, efficient means for customers to access catalytic reaction data, and tap into JMCCT’s technical knowledge on the go,” said Gerard Compagnoni, General Manager of Johnson Matthey Catalysis and Chiral Technologies. “We are very excited to introduce the app for the benefit of our customers, and are looking forward to shortly debuting the online version of the CRG to round out this resource.”
The migration to a digital platform was directly driven by customer demand for the CRG in a more manageable format than traditional print, and was formally completed and put into beta testing in late 2014. Customers may download the app for free on any iPhone, iPad or Android device. A complementary online CRG will go live on the JMCCT website in spring 2015.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance